BMO Capital raised the firm’s price target on NOV Inc. (NOV) to $20 from $19 and keeps a Market Perform rating on the shares. The company’s Q4 results were positive, though 2026 revisions were mixed with revenues slightly higher, EBITDA little changed, and EPS reduced on higher taxes, while its free cash flow outlook is trimmed on lower conversion, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NOV:
